TELO vs. LFCR, VERU, GALT, ACRV, OGI, TRVI, OMER, GLSI, RIGL, and ALIM
Should you be buying Telomir Pharmaceuticals stock or one of its competitors? The main competitors of Telomir Pharmaceuticals include Lifecore Biomedical (LFCR), Veru (VERU), Galectin Therapeutics (GALT), Acrivon Therapeutics (ACRV), Organigram (OGI), Trevi Therapeutics (TRVI), Omeros (OMER), Greenwich LifeSciences (GLSI), Rigel Pharmaceuticals (RIGL), and Alimera Sciences (ALIM). These companies are all part of the "pharmaceutical preparations" industry.
Lifecore Biomedical (NASDAQ:LFCR) and Telomir Pharmaceuticals (NASDAQ:TELO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk.
Lifecore Biomedical currently has a consensus price target of $9.50, indicating a potential upside of 51.27%. Given Telomir Pharmaceuticals' higher probable upside, research analysts clearly believe Lifecore Biomedical is more favorable than Telomir Pharmaceuticals.
83.4% of Lifecore Biomedical shares are owned by institutional investors. 14.6% of Lifecore Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Lifecore Biomedical received 1 more outperform votes than Telomir Pharmaceuticals when rated by MarketBeat users.
In the previous week, Lifecore Biomedical had 1 more articles in the media than Telomir Pharmaceuticals. MarketBeat recorded 2 mentions for Lifecore Biomedical and 1 mentions for Telomir Pharmaceuticals. Lifecore Biomedical's average media sentiment score of 1.89 beat Telomir Pharmaceuticals' score of 0.93 indicating that Telomir Pharmaceuticals is being referred to more favorably in the news media.
Telomir Pharmaceuticals has lower revenue, but higher earnings than Lifecore Biomedical.
Summary
Lifecore Biomedical beats Telomir Pharmaceuticals on 7 of the 9 factors compared between the two stocks.
Get Telomir Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TELO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Telomir Pharmaceuticals Competitors List
Related Companies and Tools
